GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Price-to-Free-Cash-Flow

Bayer AG (Bayer AG) Price-to-Free-Cash-Flow

: 10.61 (As of Today)
View and export this data going back to 2007. Start your Free Trial

As of today (2024-04-19), Bayer AG's share price is $7.065. Bayer AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.67. Hence, Bayer AG's Price-to-Free-Cash-Flow Ratio for today is 10.61.

The historical rank and industry rank for Bayer AG's Price-to-Free-Cash-Flow or its related term are showing as below:

BAYRY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.25   Med: 15.26   Max: 5187.27
Current: 11

During the past 13 years, Bayer AG's highest Price-to-Free-Cash-Flow Ratio was 5187.27. The lowest was 8.25. And the median was 15.26.

BAYRY's Price-to-Free-Cash-Flow is ranked better than
75.2% of 496 companies
in the Drug Manufacturers industry
Industry Median: 21.17 vs BAYRY: 11.00

Bayer AG's Free Cash Flow per Share for the three months ended in Dec. 2023 was $1.28. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.67.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bayer AG was -42.90% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -1.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -13.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -5.90% per year.

During the past 13 years, Bayer AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 104.60% per year. The lowest was -27.10% per year. And the median was 2.30% per year.


Bayer AG Price-to-Free-Cash-Flow Historical Data

The historical data trend for Bayer AG's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.86 19.04 18.64 11.46 13.97

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.46 47.93 - - 13.97

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Price-to-Free-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bayer AG's Price-to-Free-Cash-Flow falls into.



Bayer AG Price-to-Free-Cash-Flow Calculation

Bayer AG's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=7.065/0.666
=10.61

Bayer AG's Share Price of today is $7.065.
Bayer AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.67.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Bayer AG  (OTCPK:BAYRY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Bayer AG Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bayer AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (Bayer AG) Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (Bayer AG) Headlines

From GuruFocus

Bayer Monsanto Roundup Cancer Victims Oppose Settlement

By PRNewswire PRNewswire 03-07-2022